We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Julian Moran

Julian Moran BSc, MSc Candidate

Clinical Research Coordinator, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women´s Hospital, Boston, Massachusetts

Julian Moran is a clinical research coordinator focusing on novel therapeutics for type 2 diabetes at Brigham and Women’s Hospital in Boston Massachusetts. He received his BSc in Biochemistry from McGill University in Montreal, Canada, where he is also a Master of Science in Biochemistry candidate. During his time at McGill, Julian studied the regulation of the cellular senescence secretome, which has been found to be an important contributor to age-related diseases such as diabetes and cancer as well as a cause of chronic inflammation which accelerates aging. This collection of secreted factors is commonly referred to as the senescence associated secretory phenotype (SASP). Julian also worked on understanding the mechanisms by which senescent cells respond to stress. Julian’s clinical interests are in understanding and preventing chronic disease, with focused interest and concentration in type 2 diabetes and endocrinology. He is passionate about bridging the communication science gap between physicians and physician-scientists and patients.

Disclosures

Julian Moran has no relevant disclosures.